Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

37.59
Delayed Data
As of Sep 22
 -0.04 / -0.11%
Today’s Change
20.68
Today|||52-Week Range
40.83
+30.34%
Year-to-Date
Glaxo-Innoviva's Triple Combo Inhaler Positive in Phase III
Sep 21 / Zacks.com - Paid Partner Content
Alexion (ALXN) Reports Interim Results for Soliris Study
Sep 14 / Zacks.com - Paid Partner Content
Supernus Drops SPN-810's Lower Dose Test in Phase III Trials
Sep 19 / Zacks.com - Paid Partner Content
Perrigo's Stock Up, Starboard's CEO Calls it a Key Pick
Sep 13 / Zacks.com - Paid Partner Content
Glaxo/Innoviva's Triple Combo Therapy Gets FDA Nod for COPD
Sep 19 / Zacks.com - Paid Partner Content
Marinus Stock Surges on Successful Phase II Epilepsy Study
Sep 12 / Zacks.com - Paid Partner Content
BioMarin Says FDA Not Planning an AdCom for Pegvaliase BLA
Sep 18 / Zacks.com - Paid Partner Content
Ultragenyx's Burosumab Positive in Phase II for XLH and TIO
Sep 12 / Zacks.com - Paid Partner Content
GTx's (GTXI) Enobosarm Positive in Phase II, Shares Down
Sep 14 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close37.63
Today’s open37.66
Day’s range37.30 - 37.89
Volume867,543
Average volume (3 months)1,451,978
Market cap$4.6B
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)-8.87%
Earnings growth (next 5 years)+28.93%
Revenue growth (last year)+28,311.48%
P/E ratioNM
Price/Sales192.80
Price/Book8.80

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...+1.22+1.13%
AGNPRAAllergan plc+7.04+0.96%
AKRXAkorn Inc-0.08-0.24%
VRXValeant Pharmaceutic...-0.22-1.55%
Data as of 4:02pm ET, 09/22/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$17.3M
Annual profit (last year)-$271.4M
Net profit margin-1,565.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts